Case Study: Pharmaceutical Manufacturing Company achieves faster, less expensive drug discovery with BP3 Global

Using AI to Make Drug Research and Development Less Expensive and More Efficient

Pharmaceutical Manufacturing Company faced the industry-wide challenge of drug discovery that is long, costly, and heavily regulated — a process that can take 10 to 15 years and has been estimated to cost over $1.3 billion. To address this, BP3 Global deployed an AI- and machine learning–driven research assistant integrated with powerful process and business-rules engines to work within the company’s existing infrastructure.

BP3 Global’s solution ingests and analyzes vast amounts of scientific literature (able to review a billion structured and unstructured papers and abstracts), draws cognitive connections to hypothesize candidate drugs, and provides seamless integration, monitoring, and management. The result is faster, more intelligent research workflows that reduce time and cost in R&D; BP3 Global highlights these workflow gains and cites an unprecedented 99.9% success rate for its process-focused projects.